CytomX Therapeutics, Inc. (CTMX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 10.26M | 663K | 5.96M | 18.66M | 50.92M | 38.09M | 33.43M | 25.11M | 41.46M | 26.61M | 26.38M | 24.72M | 23.5M | 20.12M | 11.15M | 12.85M | 9.04M | 19.73M | 17.59M | 16.29M |
| Revenue Growth % | -79.85% | -98.26% | -82.16% | -25.71% | 22.8% | 43.17% | 26.71% | 1.58% | 76.45% | 32.22% | 136.69% | 92.36% | 159.94% | 2.01% | -36.62% | -21.09% | -43.4% | 20.48% | -1.13% | -1.93% |
| Cost of Goods Sold | 251K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.43M | 1.53M | 1.5M | 0 | 1.49M | 0 | 0 | 1.48M | 0 | 0 |
| COGS % of Revenue | 2.45% | - | - | - | - | - | - | - | - | - | 5.4% | 6.2% | 6.37% | - | 13.32% | - | - | 7.52% | - | - |
| Gross Profit | 10.01M | 663K | 5.96M | 18.66M | 50.92M | 38.09M | 33.43M | 25.11M | 41.46M | 26.61M | 24.96M | 23.19M | 22M | 20.12M | 9.66M | 12.85M | 9.04M | 18.24M | 17.59M | 16.29M |
| Gross Margin % | 97.55% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 94.6% | 93.8% | 93.63% | 100% | 86.68% | 100% | 100% | 92.48% | 100% | 100% |
| Gross Profit Growth % | -80.35% | -98.26% | -82.16% | -25.71% | 22.8% | 43.17% | 33.95% | 8.29% | 88.44% | 32.22% | 158.31% | 80.44% | 143.4% | 10.3% | -45.06% | -21.09% | -43.4% | 11.43% | -1.13% | -1.93% |
| Operating Expenses | 29.68M | 28.59M | 21.73M | 19.94M | 28.3M | 20.41M | 29.32M | 33.57M | 29.81M | 27.21M | 13.87M | 26.54M | 27.66M | 29.63M | 39.37M | 42.91M | 41.1M | 44.55M | 40.23M | 35.49M |
| OpEx % of Revenue | 289.33% | 4312.97% | 364.43% | 106.89% | 55.57% | 53.59% | 87.7% | 133.65% | 71.89% | 102.28% | 52.55% | 107.35% | 117.69% | 147.25% | 353.21% | 333.83% | 454.67% | 225.84% | 228.74% | 217.91% |
| Selling, General & Admin | 10.69M | 7.36M | 6.43M | 6.62M | 9.43M | 5.62M | 7.95M | 8.39M | 7.75M | 7.83M | 3.44M | 6.44M | 7.04M | 7.67M | 9.59M | 11.75M | 10.54M | 8.61M | 11.09M | 9.39M |
| SG&A % of Revenue | 104.23% | 1110.11% | 107.78% | 35.49% | 18.52% | 14.76% | 23.79% | 33.43% | 18.7% | 29.42% | 13.02% | 26.06% | 29.96% | 38.1% | 86.04% | 91.4% | 116.63% | 43.66% | 63.03% | 57.67% |
| Research & Development | 19.24M | 21.23M | 15.3M | 13.32M | 18.87M | 14.79M | 21.37M | 25.17M | 22.05M | 19.39M | 10.43M | 20.1M | 20.62M | 19.56M | 29.78M | 31.16M | 30.56M | 35.94M | 29.14M | 26.1M |
| R&D % of Revenue | 187.54% | 3202.87% | 256.65% | 71.4% | 37.06% | 38.83% | 63.91% | 100.23% | 53.18% | 72.86% | 39.53% | 81.29% | 87.73% | 97.22% | 267.17% | 242.43% | 338.04% | 182.19% | 165.71% | 160.24% |
| Other Operating Expenses | -251K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | -1 | 0 | 0 | 0 |
| Operating Income | -19.67M | -27.93M | -15.77M | -1.29M | 22.62M | 17.68M | 4.11M | -8.45M | 11.66M | -606K | 11.09M | -3.35M | -5.65M | -9.51M | -29.71M | -30.05M | -32.06M | -26.31M | -22.64M | -19.2M |
| Operating Margin % | -191.77% | -4212.97% | -264.43% | -6.89% | 44.43% | 46.41% | 12.3% | -33.65% | 28.11% | -2.28% | 42.04% | -13.54% | -24.06% | -47.25% | -266.53% | -233.83% | -354.67% | -133.36% | -128.74% | -117.91% |
| Operating Income Growth % | -186.96% | -258% | -483.56% | 84.78% | 94.06% | 3017.33% | -62.94% | -152.45% | 306.21% | 93.63% | 137.34% | 88.86% | 82.37% | 63.86% | -31.22% | -56.49% | -105.17% | -78.01% | -52% | -19% |
| EBITDA | -19.42M | -27.42M | -15.63M | -939K | 23.01M | 18.09M | 4.54M | -7.99M | 12.12M | -120K | 12.52M | -1.82M | -4.16M | -8.9M | -28.23M | -29.44M | -31.46M | -24.82M | -21.96M | -18.53M |
| EBITDA Margin % | -189.33% | -4136.05% | -262.18% | -5.03% | 45.18% | 47.49% | 13.58% | -31.83% | 29.24% | -0.45% | 47.45% | -7.35% | -17.69% | -44.23% | -253.21% | -229.08% | -348.01% | -125.84% | -124.87% | -113.75% |
| EBITDA Growth % | -184.42% | -251.57% | -444.36% | 88.25% | 89.76% | 15176.67% | -63.74% | -340.14% | 391.65% | 98.65% | 144.35% | 93.83% | 86.79% | 64.15% | -28.52% | -58.92% | -110.39% | -75.85% | -54.19% | -19.41% |
| D&A (Non-Cash Add-back) | 251K | 510K | 134K | 347K | 385K | 413K | 429K | 459K | 467K | 486K | 1.43M | 1.53M | 1.5M | 608K | 1.49M | 610K | 602K | 1.48M | 680K | 677K |
| EBIT | -19.67M | -27.93M | -14.17M | -1.29M | 22.62M | 17.68M | 4.11M | -8.45M | 11.66M | -606K | 5.82M | -1.09M | -3.31M | -2.01M | -29.06M | -30.05M | -32.06M | -26.23M | -22.64M | -19.2M |
| Net Interest Income | 1.49M | 1.48M | 1.59M | 1.18M | 955K | 1.28M | 1.69M | 1.97M | 2.19M | 2.5M | 2.7M | 2.31M | 2.33M | 732K | 616K | 262K | 68K | 73K | 70K | 44K |
| Interest Income | 1.49M | 1.48M | 1.59M | 1.18M | 955K | 1.28M | 1.69M | 1.97M | 2.19M | 2.5M | 2.7M | 2.31M | 2.33M | 732K | 616K | 262K | 68K | 73K | 70K | 44K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.48M | 1.48M | 1.6M | 1.2M | 966K | 1.26M | 1.69M | 1.97M | 2.18M | 2.51M | -5.28M | 2.26M | 2.34M | 733K | 646K | 558K | 81K | 80K | 57K | -38K |
| Pretax Income | -18.19M | -26.46M | -14.17M | -91K | 23.59M | 18.94M | 5.8M | -6.48M | 13.84M | 1.91M | 5.82M | -1.09M | -3.31M | -8.78M | -29.06M | -29.5M | -31.98M | -26.23M | -22.58M | -19.24M |
| Pretax Margin % | -177.32% | -3990.35% | -237.65% | -0.49% | 46.32% | 49.72% | 17.34% | -25.81% | 33.38% | 7.16% | 22.04% | -4.4% | -14.09% | -43.61% | -260.73% | -229.49% | -353.77% | -132.95% | -128.41% | -118.14% |
| Income Tax | 59K | 54K | 58K | 63K | 62K | 62K | 61K | 51K | 49K | 1.07M | 2.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.32% | -0.2% | -0.41% | -69.23% | 0.26% | 0.33% | 1.05% | -0.79% | 0.35% | 56.09% | 48.55% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -18.25M | -26.51M | -14.23M | -154K | 23.52M | 18.88M | 5.74M | -6.53M | 13.79M | 837K | 2.99M | -1.09M | -3.31M | -8.78M | -29.06M | -29.5M | -31.98M | -26.23M | -22.58M | -19.24M |
| Net Margin % | -177.89% | -3998.49% | -238.62% | -0.83% | 46.2% | 49.55% | 17.16% | -26.02% | 33.26% | 3.15% | 11.34% | -4.4% | -14.09% | -43.61% | -260.73% | -229.49% | -353.77% | -132.95% | -128.41% | -118.14% |
| Net Income Growth % | -177.57% | -240.44% | -348.06% | 97.64% | 70.58% | 2155.2% | 91.71% | -501.1% | 516.52% | 109.54% | 110.29% | 96.31% | 89.65% | 66.54% | -28.69% | -53.28% | -105.61% | -78.41% | -53.53% | -22.73% |
| Net Income (Continuing) | -18.25M | -26.51M | -14.23M | -154K | 23.52M | 18.88M | 5.74M | -6.53M | 13.79M | 837K | 2.99M | -1.09M | -3.31M | -8.78M | -29.06M | -29.5M | -31.98M | -26.23M | -22.58M | -19.24M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.10 | -0.17 | -0.09 | -0.00 | 0.27 | 0.24 | 0.07 | -0.08 | 0.17 | 0.01 | 0.04 | -0.02 | -0.01 | -0.40 | -0.34 | -0.36 | -0.36 | -0.40 | -0.35 | -0.30 |
| EPS Growth % | -137.04% | -170.83% | -233.73% | 98.44% | 58.82% | 1835.48% | 82.38% | -372.39% | 1264.38% | 103.1% | 110.85% | 95.47% | 95.94% | 0% | 2.86% | -20% | -38.46% | -25% | -9.38% | 11.76% |
| EPS (Basic) | -0.10 | -0.17 | -0.09 | -0.00 | 0.27 | 0.24 | 0.07 | -0.08 | 0.17 | 0.01 | 0.04 | -0.02 | -0.01 | -0.40 | -0.34 | -0.36 | -0.36 | -0.40 | -0.35 | -0.30 |
| Diluted Shares Outstanding | 177.27M | 170.19M | 165M | 129.08M | 87.15M | 80.1M | 85.2M | 84.88M | 82.63M | 67.31M | 80.99M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 65.21M | 65.06M |
| Basic Shares Outstanding | 177.27M | 170.19M | 165M | 129.08M | 87.12M | 80.1M | 85.09M | 84.88M | 82.03M | 67.31M | 80.73M | 66.54M | 66.25M | 66.23M | 65.91M | 65.54M | 65.39M | 65.21M | 64.53M | 65.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |